Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 84501-84550 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05061576
Instructed Home-based Physical Exercise for Patients With Liver Cirrhosis
NARecruiting
100 participants
Started: Aug 16, 2022 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT05190471
A Clinical Trial of BP1002 in Patients With Refractory/Relapsed Acute Myeloid Leukemia (AML)
PHASE1Recruiting
48 participants
Started: Aug 16, 2022 · Completed: Sep 30, 2027
2 conditions1 sponsor4 locations
NCT06963853
Evaluation of Microbial and Endocrinological Parameters in Dialysis Patients With Sepsis
N/ARecruiting
200 participants
Started: Aug 16, 2022 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT06205992
3D-MRE and 2D-MRE for Assessing Cirrhosis and Portal Hypertension
N/ARecruiting
100 participants
Started: Aug 16, 2022 · Completed: Dec 1, 2025
2 conditions1 sponsor1 location
NCT05583448
MDR ExploR Radial Head System PMCF
N/AEnrolling by invitation
93 participants
Started: Aug 16, 2022 · Completed: Jul 19, 2035
1 condition1 sponsor2 locations
NCT03915691
The RIPPLE AT-PLUS Study
NAActive, not recruiting
201 participants
Started: Aug 16, 2022 · Completed: Apr 30, 2026
1 condition8 sponsors3 locations
NCT05478720
DON in Pediatric Cerebral Malaria
PHASE1/PHASE2Recruiting
152 participants
Started: Aug 16, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors2 locations
NCT05959031
Parameter Space of kTMP
NAEnrolling by invitation
200 participants
Started: Aug 16, 2022 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT05234125
Better Lifestyle Counseling for African American Women During Pregnancy
NARecruiting
150 participants
Started: Aug 16, 2022 · Completed: Apr 30, 2027
12 conditions4 sponsors2 locations
NCT05519072
Use of Prophylactic Antibiotics Prior to OnabotulinumtoxinA
PHASE4Recruiting
140 participants
Started: Aug 16, 2022 · Completed: Aug 16, 2024
1 condition2 sponsors1 location
NCT05274919
Vascular Signature Mapping of Brain Tumor Genotypes
N/ARecruiting
180 participants
Started: Aug 16, 2022 · Completed: Mar 31, 2026
1 condition2 sponsors2 locations
NCT05489705
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
N/ARecruiting
1,600 participants
Started: Aug 16, 2022 · Completed: Aug 17, 2029
1 condition1 sponsor98 locations
NCT07041710
Rehabilitation of Taste and Smell Disorders Associated With Chemotherapy Using Aromatherapy
NARecruiting
104 participants
Started: Aug 16, 2022 · Completed: Jul 30, 2027
1 condition1 sponsor1 location
NCT04306315
Adjusted Brodalumab Dose Compared With Standard Brodalumab Dose in Subjects With Moderate-to-severe Plaque Psoriasis and ≥120 kg Body Weight
PHASE4Active, not recruiting
385 participants
Started: Aug 16, 2022 · Completed: Dec 29, 2025
1 condition1 sponsor81 locations
NCT05439850
Bioinductive Patch for Full-Thickness Rotator Cuff Tears
PHASE4Recruiting
78 participants
Started: Aug 16, 2022 · Completed: Dec 1, 2027
2 conditions1 sponsor1 location
NCT05475015
3D-MRE for Assessing Cirrhosis, Advanced Chronic Liver Disease and Portal Hypertension
N/ARecruiting
100 participants
Started: Aug 16, 2022 · Completed: Dec 1, 2025
3 conditions2 sponsors1 location
NCT05305365
Study Assessing QBS72S For Treating Brain Metastases
PHASE2Active, not recruiting
21 participants
Started: Aug 16, 2022 · Completed: Nov 30, 2025
5 conditions2 sponsors1 location
NCT04927897
DETECT: Target Volume for Rectal Endoluminal Radiation Boosting
N/ARecruiting
50 participants
Started: Aug 16, 2022 · Completed: Dec 31, 2027
1 condition3 sponsors3 locations
NCT05501717
Safety, PK/PD, and Immunogenicity Study of SC ALXN2030 in Healthy Participants
PHASE1Active, not recruiting
48 participants
Started: Aug 16, 2022 · Completed: Oct 30, 2026
1 condition1 sponsor1 location
NCT05469698
Onsite Tobacco Cessation Treatment for Patients With PAD
NAActive, not recruiting
15 participants
Started: Aug 16, 2022 · Completed: Jul 31, 2024
2 conditions1 sponsor1 location
NCT05502341
Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen
PHASE2/PHASE3Active, not recruiting
689 participants
Started: Aug 16, 2022 · Completed: Jul 31, 2028
1 condition1 sponsor94 locations
NCT05489926
A Study to Explore Pamiparib Treatment in Epithelial Ovarian Cancer After Prior PARP Inhibitor Exposure
PHASE2Active, not recruiting
15 participants
Started: Aug 16, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT06522971
Effects of Physical Exercise on Response to Treatement in Breast Cancer
NAActive, not recruiting
55 participants
Started: Aug 16, 2022 · Completed: Dec 30, 2027
1 condition3 sponsors1 location
NCT05598645
Thulium Fiber Laser (TFL) Versus Holmium MOSES Laser for Ureteroscopic Management of Kidney Stones
NARecruiting
174 participants
Started: Aug 16, 2022 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT05549024
68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients
EARLY_PHASE1Recruiting
90 participants
Started: Aug 16, 2022 · Completed: Dec 31, 2026
4 conditions1 sponsor1 location
NCT07213726
Quantification of Progenitor Cell Circulation Following Vascular Resistance Exercise Using Delfi Tourniquet System
NAActive, not recruiting
15 participants
Started: Aug 16, 2022 · Completed: Nov 20, 2026
1 condition2 sponsors1 location
NCT05322850
Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)
PHASE1/PHASE2Recruiting
40 participants
Started: Aug 16, 2022 · Completed: Sep 30, 2027
7 conditions3 sponsors4 locations
NCT05393284
Phase 2 Spectra Study to Evaluate the Safety and Efficacy of OPL-0401 in Patients With Diabetic Retinopathy
PHASE2Active, not recruiting
114 participants
Started: Aug 16, 2022 · Completed: Aug 31, 2024
2 conditions1 sponsor25 locations
NCT06696716
ONO-4059 Study in Patients With Steroid-resistant Pemphigus
PHASE3Recruiting
34 participants
Started: Aug 15, 2022 · Completed: Mar 31, 2029
2 conditions1 sponsor20 locations
NCT05551208
Fluzoparib Combined With Bevacizumab in PSROC Previously Treated With PARPi
PHASE2Recruiting
42 participants
Started: Aug 15, 2022 · Completed: Aug 30, 2029
1 condition1 sponsor1 location
NCT05140499
Liposomal Bupivacaine vs Continuous Nerve Catheters for Below the Knee Amputations
PHASE4Recruiting
30 participants
Started: Aug 15, 2022 · Completed: Jan 31, 2026
2 conditions2 sponsors1 location
NCT05463991
Bioengineered Collagen Implant for Urethral Stricture Repair
NARecruiting
5 participants
Started: Aug 15, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05389046
Study on the Optimal Diagnosis and Treatment Strategy of Major Depressive Disorder Based on Anhedonia
NARecruiting
252 participants
Started: Aug 15, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor3 locations
NCT06337201
A Digital Life Story to Support Person-centred Care for Older Adults With Dementia Perspectives
N/ARecruiting
30 participants
Started: Aug 15, 2022 · Completed: Jun 30, 2027
2 conditions1 sponsor1 location
NCT06125301
Multiple Sclerosis Self Monitoring Study
NARecruiting
225 participants
Started: Aug 15, 2022 · Completed: Aug 15, 2024
1 condition1 sponsor1 location
NCT05494606
An Observational Study to Assess Change in Disease Activity and Adverse Events of Upadacitinib in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Real-World Practice
N/AActive, not recruiting
785 participants
Started: Aug 15, 2022 · Completed: Mar 31, 2028
1 condition1 sponsor153 locations
NCT05227677
Value of Glycated Albumin in Intervention of Glycemic Control in Chinese Patients With Type 2 Diabetes
NAActive, not recruiting
200 participants
Started: Aug 15, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor7 locations
NCT05454176
Diabetes in African Youth
PHASE4Recruiting
180 participants
Started: Aug 15, 2022 · Completed: Aug 15, 2027
1 condition1 sponsor1 location
NCT05504330
Cognitive Decline and Underlying Mechanisms in Asymptomatic Intracranial Artery Stenosis Patients
N/ARecruiting
100 participants
Started: Aug 15, 2022 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT05415488
Dietary Treatment for IBS Within Primary Health Care
NARecruiting
240 participants
Started: Aug 15, 2022 · Completed: Sep 15, 2025
1 condition1 sponsor1 location
NCT06428669
Effect of Nitropaste in Chest Masculinizing Surgery
PHASE4Recruiting
256 participants
Started: Aug 15, 2022 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT07186881
Evolving Diagnostic Approaches to Undocumented Lymphocytic Meningitis and Meningoencephalitis
N/AEnrolling by invitation
200 participants
Started: Aug 15, 2022 · Completed: Aug 15, 2026
4 conditions1 sponsor1 location
NCT05452642
The Supporting Understanding of PCOS Education and Research (SUPER) Study
NAActive, not recruiting
223 participants
Started: Aug 15, 2022 · Completed: Jul 15, 2026
1 condition2 sponsors1 location
NCT05918380
Project 3: ACHIEVE- CHD
NARecruiting
500 participants
Started: Aug 15, 2022 · Completed: Jan 1, 2027
1 condition1 sponsor1 location
NCT05473689
Outcomes Post Treatment: Impact on Motor Impairment of Sleep Efficiency in SCI (OPTIMISE SCI Trial)
NARecruiting
66 participants
Started: Aug 15, 2022 · Completed: Jul 31, 2025
2 conditions2 sponsors1 location
NCT05479552
A Diagnostic Test for Dementia With Lewy Bodies
N/AActive, not recruiting
80 participants
Started: Aug 15, 2022 · Completed: Oct 31, 2025
2 conditions2 sponsors12 locations
NCT05249101
A Study of Ivaltinostat Plus Capecitabine or Capecitabine in Metastatic Pancreatic Adenocarcinoma
PHASE1/PHASE2Recruiting
70 participants
Started: Aug 15, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor16 locations
NCT05561153
Central Neuromuscular Dysfunction in Patellofemoral Pain
N/AEnrolling by invitation
40 participants
Started: Aug 15, 2022 · Completed: Dec 24, 2025
1 condition1 sponsor1 location
NCT05396001
LowSalt4Life: A Mobile Application to Reduce Sodium Intake And Blood Pressure
NARecruiting
400 participants
Started: Aug 15, 2022 · Completed: Nov 30, 2025
2 conditions2 sponsors1 location
NCT05316571
Sitting Interruption and Whole-body Cardiovascular Health
NARecruiting
56 participants
Started: Aug 15, 2022 · Completed: Feb 28, 2026
2 conditions2 sponsors1 location